Investment Analysts’ Weekly Ratings Changes for iRhythm Technologies (IRTC)

iRhythm Technologies (NASDAQ: IRTC) recently received a number of ratings updates from brokerages and research firms:

• 5/5/2025 – iRhythm Technologies was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating.
• 5/2/2025 – iRhythm Technologies was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating. They now have a $130.00 price target on the stock, up previously from $104.00.
• 5/2/2025 – iRhythm Technologies had its price target raised by analysts at Robert W. Baird from $133.00 to $150.00. They now have an “outperform” rating on the stock.
• 5/2/2025 – iRhythm Technologies had its price target lowered by analysts at Canaccord Genuity Group Inc. from $152.00 to $139.00. They now have a “buy” rating on the stock.
• 5/2/2025 – iRhythm Technologies had its price target raised by analysts at Needham & Company LLC from $138.00 to $151.00. They now have a “buy” rating on the stock.

iRhythm Technologies Trading Up 1.4%

Shares of NASDAQ IRTC opened at $139.78 on Wednesday. iRhythm Technologies, Inc. has a 1-year low of $55.92 and a 1-year high of $141.39. The company has a 50-day moving average of $108.28 and a two-hundred day moving average of $99.93. The company has a market cap of $4.46 billion, a PE ratio of -38.40 and a beta of 1.34. The company has a current ratio of 6.27, a quick ratio of 6.12 and a debt-to-equity ratio of 9.00.

iRhythm Technologies (NASDAQ:IRTC) last issued its quarterly earnings results on Thursday, May 1st. The company reported ($0.95) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.89) by ($0.06). iRhythm Technologies had a negative net margin of 19.14% and a negative return on equity of 118.83%. The company had revenue of $158.68 million during the quarter, compared to analyst estimates of $153.39 million. During the same period in the prior year, the business earned ($1.23) EPS. The business’s revenue for the quarter was up 20.3% on a year-over-year basis. As a group, equities analysts expect that iRhythm Technologies, Inc. will post -1.98 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. MCF Advisors LLC bought a new stake in shares of iRhythm Technologies during the first quarter worth approximately $25,000. R Squared Ltd bought a new stake in shares of iRhythm Technologies during the 4th quarter valued at $45,000. Van ECK Associates Corp raised its position in shares of iRhythm Technologies by 41.3% during the 4th quarter. Van ECK Associates Corp now owns 554 shares of the company’s stock valued at $50,000 after acquiring an additional 162 shares during the last quarter. CWM LLC lifted its stake in shares of iRhythm Technologies by 54.3% in the 1st quarter. CWM LLC now owns 517 shares of the company’s stock valued at $54,000 after purchasing an additional 182 shares during the period. Finally, Raiffeisen Bank International AG bought a new position in shares of iRhythm Technologies in the 4th quarter worth $60,000.

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.